Literature DB >> 1965840

Laminin-mediated process formation in neuronal cells involves protein dephosphorylation.

B S Weeks1, J DiSalvo, H K Kleinman.   

Abstract

Laminin mediates neural adhesion and process formation. A possible signal transduction pathway for laminin was investigated in both NG108-15 and PC12 neuronal cells using radiolabeling studies as well as various stimulators and inhibitors of phosphatases and kinases. Using [32P]-ortho-phosphate, laminin caused a decrease in the TCA-precipitable counts. Further, laminin stimulated dephosphorylation of laminin binding proteins of 110 kDa, 67 kDa, and 45 kDa and this dephosphorylation was blocked by the phosphatase inhibitor, okadaic acid, and the protein kinase C stimulator, TPA. The phosphatase inhibitors okadaic acid and vanadate, as well as the protein kinase C stimulators, TPA and DAG, blocked laminin-mediated process formation. Inhibitors of kinase activity such as H-7, H-8, and H-9 increased laminin-mediated neural process formation. Since phosphate incorporation into laminin-binding proteins is decreased by laminin and because both phosphatase inhibitors and kinase stimulators inhibit laminin-mediated process formation, we conclude that dephosphorylation events promote the neural cell response to laminin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965840     DOI: 10.1002/jnr.490270321

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

Review 1.  Role of laminin and integrin interactions in growth cone guidance.

Authors:  L McKerracher; M Chamoux; C O Arregui
Journal:  Mol Neurobiol       Date:  1996-04       Impact factor: 5.590

Review 2.  Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.

Authors:  Vincent DiGiacomo; Daniel Meruelo
Journal:  Biol Rev Camb Philos Soc       Date:  2015-01-28

Review 3.  Regulation of cell function by extracellular matrix.

Authors:  H W Schnaper; H K Kleinman
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

4.  Anti-LRP/LR specific antibody IgG1-iS18 significantly impedes adhesion and invasion in early and late stage colorectal carcinoma cells.

Authors:  Leila Vania; Carryn J Chetty; Eloise Ferreira; Stefan F T Weiss
Journal:  Mol Med       Date:  2016-09-08       Impact factor: 6.354

5.  Reversible structural alterations of undifferentiated and differentiated human neuroblastoma cells induced by phorbol ester.

Authors:  I S Tint; E M Bonder; H H Feder; C P Reboulleau; J M Vasiliev; I M Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells.

Authors:  R Reich; M Blumenthal; M Liscovitch
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

7.  Adhesion of Trypanosoma cruzi trypomastigotes to fibronectin or laminin modifies tubulin and paraflagellar rod protein phosphorylation.

Authors:  Eliciane C Mattos; Robert I Schumacher; Walter Colli; Maria Julia M Alves
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

8.  Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.

Authors:  Carryn Chetty; Thandokuhle Khumalo; Bianca Da Costa Dias; Uwe Reusch; Stefan Knackmuss; Melvyn Little; Stefan F T Weiss
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  Upregulation of LAMB1 via ERK/c-Jun Axis Promotes Gastric Cancer Growth and Motility.

Authors:  Hana Lee; Won-Jin Kim; Hyeon-Gu Kang; Jun-Ho Jang; Il Ju Choi; Kyung-Hee Chun; Seok-Jun Kim
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

10.  Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen.

Authors:  V M Paralkar; B S Weeks; Y M Yu; H K Kleinman; A H Reddi
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.